Italia markets closed
FTSE MIB
34.657,35 +1.028,15 (+3,06%) Dow Jones
39.512,84 +125,04 (+0,32%) Nasdaq
16.340,87 +184,57 (+1,14%) Nikkei 225
38.229,11 -44,99 (-0,12%) Petrolio
78,20 -0,06 (-0,08%) Bitcoin EUR
56.968,03 +265,94 (+0,47%)
DVA Jan 2025 150.000 call
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
In data: 12:11PM EDT. Mercato aperto.
| Chiusura precedente | 9,80 |
| Aperto | 9,80 |
| Denaro | 10,80 |
| Lettera | 11,20 |
| Prezzo d'esercizio | 150,00 |
| Scadenza | 2025-01-17 |
| Min-Max giorno | 9,80 - 9,80 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 49 |
GlobeNewswireNuwellis Inc. Announces Pilot Agreement With DaVita Inc.
Supply Agreement to Pilot Ultrafiltration Therapy Services Offering in Select MarketsMINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced it has entered into a Supply and Collaboration Agreement with DaVita Inc. (NYSE: DVA) to pilot Aquadex ultrafiltration therapy to treat adult patients with congestive heart failure and related conditions within select U.S. mark
© 2024 Yahoo. Tutti i diritti riservati.